Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.251.181.491.371.03

What is the latest Working Capital/Sales ratio of BLISS GVS PHARMA ?

The latest Working Capital/Sales ratio of BLISS GVS PHARMA is 1.25 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.25
Mar20241.18
Mar20231.49
Mar20221.37
Mar20211.03

How is Working Capital/Sales of BLISS GVS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.25
5.93
Mar2024 1.18
-20.81
Mar2023 1.49
8.76
Mar2022 1.37
33.01
Mar2021 1.03 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Working Capital/Sales ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,637.3 Cr -6.5% -0.1% -4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,248.0 Cr -0.2% 5.8% 0.9% Stock Analytics
DIVIS LABORATORIES ₹171,344.0 Cr -0.6% -5.2% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,832.0 Cr -0.5% 2.5% 12.1% Stock Analytics
CIPLA ₹121,820.0 Cr -1.1% -0.2% -1.2% Stock Analytics
DR REDDYS LABORATORIES ₹106,877.0 Cr 2.4% 7% 6.2% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-6.5%

-0.1%

-4.6%

SENSEX

-0.6%

1.4%

7.7%


You may also like the below Video Courses